Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Retatrutide for Sale > Retatrutide | US Warehouse | GLP-1 GIP GCG Triple Agonist Peptide | 99% Purity | 10mg 15mg 20mg 30mg Vials | Lyophilized Powder
Retatrutide | US Warehouse | GLP-1 GIP GCG Triple Agonist Peptide | 99% Purity | 10mg 15mg 20mg 30mg Vials | Lyophilized Powder buy - large image1
Retatrutide | US Warehouse | GLP-1 GIP GCG Triple Agonist Peptide | 99% Purity | 10mg 15mg 20mg 30mg Vials | Lyophilized Powder buy - image1
Retatrutide | US Warehouse | GLP-1 GIP GCG Triple Agonist Peptide | 99% Purity | 10mg 15mg 20mg 30mg Vials | Lyophilized Powder buy - image2
Retatrutide | US Warehouse | GLP-1 GIP GCG Triple Agonist Peptide | 99% Purity | 10mg 15mg 20mg 30mg Vials | Lyophilized Powder buy - image3
Retatrutide | US Warehouse | GLP-1 GIP GCG Triple Agonist Peptide | 99% Purity | 10mg 15mg 20mg 30mg Vials | Lyophilized Powder buy - image4
Retatrutide | US Warehouse | GLP-1 GIP GCG Triple Agonist Peptide | 99% Purity | 10mg 15mg 20mg 30mg Vials | Lyophilized Powder buy - image5
Retatrutide | US Warehouse | GLP-1 GIP GCG Triple Agonist Peptide | 99% Purity | 10mg 15mg 20mg 30mg Vials | Lyophilized Powder buy - image6

Retatrutide | US Warehouse | GLP-1 GIP GCG Triple Agonist Peptide | 99% Purity | 10mg 15mg 20mg 30mg Vials | Lyophilized Powder

6823 Inquiries

Unit Price:

$30-35/UNIT FOB

Get Latest Price
CAS No.:

2381089-83-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

SZ

Brand:

TY

Packaging:

5mg,10vials/box

Price valid (until):

2026-09-11

Company Type:
Distributor
Location:
China
Qualification:
Main Products:

GLP-1,Retatrutide,Selank,Tirzepatide,MOTS-c

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Overview  


    Retatrutide, also known as LY3437943, is a novel synthetic triple receptor agonist peptide targeting GLP-1, GIP and GCGR. It belongs to the next-generation incretin research compound, widely applied in metabolic biochemistry, endocrinology and preclinical signal pathway investigation. Distinct from dual-receptor peptide analogs, this molecule can interact with three key metabolic receptors simultaneously, delivering multi-pathway regulatory characteristics for laboratory study.

    Our Retatrutide is supplied as white lyophilized powder, manufactured by solid-phase peptide synthesis followed by multi-step chromatographic purification. The product purity reaches 99% verified by HPLC, with strict control of heteropeptides, residual solvents and heavy metal contaminants. Consistent batch quality ensures high repeatability for academic research and preclinical pharmacological experiments. We maintain inventory in the US warehouse to support fast local dispatch and shorten transit lead time for North American buyers.

    Shop Retatrutide | US Warehouse | GLP-1 GIP GCG Triple Agonist Peptide | 99% Purity | 10mg 15mg 20mg 30mg Vials | Lyophilized Powder-Detailed Image 1
    Shop Retatrutide | US Warehouse | GLP-1 GIP GCG Triple Agonist Peptide | 99% Purity | 10mg 15mg 20mg 30mg Vials | Lyophilized Powder-Detailed Image 2
    Shop Retatrutide | US Warehouse | GLP-1 GIP GCG Triple Agonist Peptide | 99% Purity | 10mg 15mg 20mg 30mg Vials | Lyophilized Powder-Detailed Image 3
    Shop Retatrutide | US Warehouse | GLP-1 GIP GCG Triple Agonist Peptide | 99% Purity | 10mg 15mg 20mg 30mg Vials | Lyophilized Powder-Detailed Image 4
    Shop Retatrutide | US Warehouse | GLP-1 GIP GCG Triple Agonist Peptide | 99% Purity | 10mg 15mg 20mg 30mg Vials | Lyophilized Powder-Detailed Image 5
    Shop Retatrutide | US Warehouse | GLP-1 GIP GCG Triple Agonist Peptide | 99% Purity | 10mg 15mg 20mg 30mg Vials | Lyophilized Powder-Detailed Image 6

    As a triple agonist for GLP-1R, GIPR and GCGR, Retatrutide participates in integrated metabolic signal regulation. It modulates glucose-dependent insulin secretion and glucagon output, serving as a key tool compound to explore glucose homeostasis mechanisms.

    The synergistic activation of the three receptor pathways makes it a valuable research material for studying gastrointestinal transit rhythm, nutrient metabolism, hepatic glucose turnover and energy expenditure related signaling networks. With fatty acid side-chain structural modification, this peptide shows strong albumin-binding affinity and extended biological half-life, making it suitable for long-cycle metabolic model research and chronic intervention experiments.

    This compound is broadly adopted for academic projects including endocrine signaling research, lipid metabolism mechanism exploration, preclinical pharmacology, and comparative study between triple agonists and dual GLP-1/GIP analogs. It provides unique molecular support for investigating multi-hormone metabolic regulation systems.

    1. High Purity Standard: ≥99% HPLC-tested purity, refined purification workflow to minimize impurities, meets requirements for high-level biochemical research.

    2. Complete Batch Documentation: Every lot is accompanied by COA, HPLC chromatogram and MS identification report for authenticity and purity verification.

    3. Stable Batch Consistency: Fixed synthesis and purification protocol reduces inter-batch deviation, helping researchers obtain stable and reproducible experimental data.

    4. US Local Stock: Inventory available in US warehouse for rapid shipment, shorter delivery cycle and lower risk of international customs delays.

    5. Good Stability & Solubility: Lyophilized form protects peptide activity; favorable solubility in suitable aqueous solvent for preparing experimental working solutions.


      Specifications & Packaging


    • Product Name: Retatrutide

    • CAS No.: 2381089-83-2

    • Appearance: White lyophilized powder

    • Purity: ≥99% (HPLC)

    • Available Vial Specifications: 10mg, 15mg, 20mg, 30mg per vial

    • Custom Service: Support custom vial packaging, labeling and bulk powder supply according to laboratory research needs

    Storage & Shelf Life

    To preserve biological activity, store sealed lyophilized powder in dry, dark and low-temperature environment. Recommended condition: -20℃ sealed storage, avoid moisture, high temperature and repeated freeze-thaw cycles. Under proper storage, the shelf life can reach 24 months.

    Supply & Customer Service

    We are a specialized supplier of high-purity research peptides and biochemical raw materials. With US warehouse stock, we support sample testing, small trial orders and bulk wholesale. Secure professional packaging is adopted to protect peptide stability during transit.

    Our sales and technical team can offer guidance on storage, reconstitution and technical parameters. We aim to provide competitive pricing, reliable quality and responsive after-sales support, building long-term cooperative partnerships with global laboratories, research institutes and biotech enterprises.


    Shop Retatrutide | US Warehouse | GLP-1 GIP GCG Triple Agonist Peptide | 99% Purity | 10mg 15mg 20mg 30mg Vials | Lyophilized Powder-Detailed Image 7
    Shop Retatrutide | US Warehouse | GLP-1 GIP GCG Triple Agonist Peptide | 99% Purity | 10mg 15mg 20mg 30mg Vials | Lyophilized Powder-Detailed Image 8
    Shop Retatrutide | US Warehouse | GLP-1 GIP GCG Triple Agonist Peptide | 99% Purity | 10mg 15mg 20mg 30mg Vials | Lyophilized Powder-Detailed Image 9
    Shop Retatrutide | US Warehouse | GLP-1 GIP GCG Triple Agonist Peptide | 99% Purity | 10mg 15mg 20mg 30mg Vials | Lyophilized Powder-Detailed Image 10

    Salesperson:Genevieve

    whatsapp:+86155 3361 7103

    ECHEMI Editorial Reference
    Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.

    Basic Info
    Product Name:

    Retatrutide

    Other Name:

    Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide

    CAS No.:

    2381089-83-2

    Molecular Formula:

    C221H342N46O68

    InChIKeys:

    MLOLQJNKXBNWFW-SAGGEDDASA-N

    Molecular Weight:

    4731.33

    EC Number:

    200-001-8

    Color/Form:

    White lyophilized

    Characteristics
    Water Solubility:

    Soluble in water (5mg/ml).

    Storage Conditions:

    -20°C

    Critical Temperature & Pressure:

    -20°C

    Research
    Class:

    Triple agonist — GCGR, GIPR, GLP-1R

    Status:

    Investigational (Phase 3)

    Mechanism:

    Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

    EC50 (Human GCGR):

    5.79 nM

    EC50 (Mouse GIPR):

    0.191 nM

    EC50 (Mouse GLP1R):

    0.794 nM

    EC50 (Mouse GCGR):

    2.32 nM

    EC50 (Human GLP1R):

    0.775 nM

    EC50 (Human GIPR):

    0.0643 nM

    Source:

    Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

    Clinical Development:

    NCT04881760; NCT05882045; NCT06354660

    References
    ChEMBL:

    CHEMBL5095485

    DrugBank:

    DB18993

    KEGG DRUG:

    D12430

    PubChem:

    PubChem

    Disclaimer:

    Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Distributor

    Main Products:

    GLP-1,Retatrutide,Selank,Tirzepatide,MOTS-c

    Location:

    Room 704#-A010, Building 11, Block 16, Liangzhu Street, Yuhang District, Hangzhou City, Zhejiang Province

    Payment Terms:

    TT against copy of documents,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    1

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    11-50

    Year of Establishment:

    2025

  • Inquiry History
    6823 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Retatrutide 2381089-83-2

    3 MT Mar 28, 2026
    United Kingdom

    Retatrutide - 2381089-83-2

    1 G Feb 10, 2026
    United States

    Retatrutide CAS 2381089-83-2 10mg vial

    20 MT Mar 7, 2026
    United States

    Factory Retatrutide API 99% Purity CAS 2381089-83-2

    5 KG Nov 10, 2025
    United Kingdom

    Peptide powder Retatrutide 99% pure for Body building cas 2381089-83-2 Weight Loss Peptide with COA

    1 MT Mar 22, 2026
    United States

    2381089-83-2

    100 G Jul 14, 2026
    United States

    2381089-83-2

    100 G Feb 24, 2026
    United States

    2381089-83-2

    100 MT Dec 9, 2023
    United States

    Retatrutide 2381089-83-2

    200 MG May 16, 2026
    United Kingdom

    2381089-83-2 retatrutide

    300 MG Feb 13, 2026
    United States

    Retatrutide 2381089-83-2 wholesale

    500 MT Nov 3, 2023
    United States

    Retatrutide CAS 2381089-83-2 99%

    10 PCS Feb 21, 2026
    Poland

    CAS 2381089-83-2 (Custom Peptide)

    40 MT Apr 10, 2026
    Austria

    Peptide Retatruide CAS 2381089-83-2

    100 MT Apr 4, 2026
    Austria

    Retatrutide CAS 2381089-83-2 10mg vial

    20 PCS Feb 10, 2026
    United States

    Tirzepatide 99.9% Liquid 2381089-83-2 TeruiOP

    1 MT Sep 6, 2023
    United States

    Retatrutide/LY3437943/GIPR/GLP-1R 98% Powder 2381089-83-2 Senwayer

    1 G Sep 3, 2023
    United States

    GLP-1 / GIP Retatrutide cas 2381089-83-2

    1 MT Oct 16, 2024
    United States

    Retatrutide 99% High Quality CAS 2381089-83-2

    1 G Jan 23, 2026
    United States

    Injection Peptide Tirzepatide/Retatrutide/ Semaglutide Peptides CAS 2381089-83-2

    10  Oct 21, 2023
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.